With the emergence of new coronavirus variants, the FDA has suspended licensing of Evusheld
CNN – The US Food and Drug Administration on Thursday Disable emergency use authorization from Evusheld because it does not appear to protect against Covid-19 viral variants currently circulating in the United States. Evusheld is a monoclonal antibody treatment used to prevent Covid-19 in immunocompromised people, who are less likely to produce an immune response …
